azathioprine has been researched along with c-peptide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertuzzi, F; Braghi, S; Davalli, AM; Falqui, L; Freschi, M; Gavazzi, F; Maffi, P; Ricordi, C; Secchi, A; Socci, C | 1 |
| Goñi, F; Goñi, MJ; Moncada, E; Monreal, M; Oleaga, A; Sánchez-Ibarrola, A; Sevilla, M; Subirá, ML; Terán, D; Yoldi, A | 1 |
| Colman, PG; Cook, JJ; Court, JM; Dean, B; Harrison, LC; Hudson, I; Warne, GL; Werther, GA | 1 |
| Johnson, S; Maclaren, N; Radjenovic, D; Riley, W; Silverstein, J; Spillar, R | 1 |
| Assan, R; Feutren, G; Sirmai, J | 1 |
| Baxter, R; Colman, PG; Dean, B; Harrison, LC; Martin, FI | 1 |
| Buckels, J; Cramb, R; Dousset, B; Krentz, AJ; Mayer, D; McMaster, P; Nattrass, M; Smith, JM | 1 |
| Ansara, MF; Brennan, DC; Cryer, PE; Flavin, KS; Lacy, PE; Scharp, DW; White, NH; Zukosky, JM | 1 |
| Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Karam, G; Murat, A; Paineau, J; Soulillou, JP | 1 |
| Christiaans, MH; van Duijnhoven, EM; van Hooff, JP | 1 |
| Battezzati, A; Cantarovich, D; Elli, A; Luzi, L; Picena Sereni, L; Soulillou, JP | 1 |
8 trial(s) available for azathioprine and c-peptide
| Article | Year |
|---|---|
Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
Topics: Adolescent; Adult; Azathioprine; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Humans; Immunophenotyping; Immunotherapy; Insulin; Interleukin-2; Islets of Langerhans; Lymphocyte Activation; Male; Receptors, Interleukin-2; T-Lymphocyte Subsets; Thymus Extracts | 1990 |
Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.
Topics: Azathioprine; Blood Glucose; C-Peptide; Child; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Insulin; Male | 1989 |
Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; C-Peptide; Child; Child, Preschool; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hemoglobin A; Humans; Immunosuppressive Agents; Islets of Langerhans; Male; Prednisone; Random Allocation; Time Factors | 1988 |
Cyclosporine trials in diabetes: updated results of the French experience.
Topics: Autoimmune Diseases; Azathioprine; C-Peptide; Clinical Trials as Topic; Cyclosporins; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Humans; Insulin; Prednisone; Recurrence | 1988 |
Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine.
Topics: Adolescent; Adult; Azathioprine; Blood Glucose; C-Peptide; Clinical Trials as Topic; Cyclosporins; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Male; Middle Aged; Random Allocation | 1985 |
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
Topics: Analysis of Variance; Azathioprine; Blood Glucose; Body Mass Index; C-Peptide; Cyclosporine; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Glycerol; Humans; Insulin; Ketone Bodies; Lactates; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyruvates; Pyruvic Acid; Reference Values; Tacrolimus | 1993 |
Modification of methodology results in improvement in simultaneous kidney-islet success.
Topics: Antilymphocyte Serum; Azathioprine; C-Peptide; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppression Therapy; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Failure, Chronic; Kidney Transplantation; Muromonab-CD3; Postoperative Complications; Prednisone; Tissue Preservation; Transplantation, Heterotopic; Transplantation, Homologous | 1995 |
Tacrolimus and glucose metabolism.
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Glucose; C-Peptide; Cyclosporine; Female; Fructosamine; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Prednisone; Prospective Studies; Regression Analysis; Tacrolimus | 1999 |
3 other study(ies) available for azathioprine and c-peptide
| Article | Year |
|---|---|
Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Blood Glucose; C-Peptide; Cell Separation; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Histocompatibility Testing; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Transplantation; Monitoring, Physiologic; Prednisone; Tissue and Organ Procurement | 1991 |
Simultaneous pancreatic and kidney transplantation before end-stage chronic renal failure.
Topics: Adult; Azathioprine; Blood Glucose; C-Peptide; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation | 1993 |
Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Blood Glucose; C-Peptide; Cyclophosphamide; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Kidney Transplantation; Kinetics; Male; Pancreas Transplantation; Prednisone | 2003 |